Pedicelli Alessandro, Michel René P, Krassakopoulos Nick
Division of Internal Medicine, Department of Medicine, McGill University, Montreal, QC, Canada.
Department of Pathology, McGill University, Montreal, QC, Canada.
Case Rep Hematol. 2024 Apr 2;2024:6964818. doi: 10.1155/2024/6964818. eCollection 2024.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and often fatal syndrome of immune hyperactivation, cytokine dysregulation, and severe inflammation. This severe syndrome is commonly triggered by infection, malignancy, autoimmunity, or immunosuppression. We present herein the case of a 56-year-old-female diagnosed with HLH triggered by an acute cytomegalovirus (CMV) infection with viremia in the context of immunosuppression for inflammatory bowel disease. This case highlights the importance of utilizing multiple diagnostic tools, prompt initiation of anti-hemophagocytic treatment, and management of the underlying etiology, to prevent significant morbidity and mortality.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见且常致命的综合征,其特征为免疫过度激活、细胞因子失调和严重炎症。这种严重综合征通常由感染、恶性肿瘤、自身免疫或免疫抑制引发。我们在此报告一例56岁女性患者,其在因炎症性肠病接受免疫抑制治疗的背景下,被诊断为由急性巨细胞病毒(CMV)感染伴病毒血症引发的HLH。该病例强调了使用多种诊断工具、及时启动抗噬血细胞治疗以及处理潜在病因以预防严重发病和死亡的重要性。